Micron Technology climbed 3.2% to $285.07, putting the memory chip maker on track for a record close. The company had a ...

Novo Nordisk surges after U.S. regulators approve the first GLP-1 pill, while shares of rival pharma giant Eli Lilly decline.

Asian stocks edged higher in thin trade Friday as Japanese and South Korean shares gained while many regional markets ...

Here are 10 of CFRA analysts' top growth stocks to buy that have reported at least 15% annual revenue growth in the past ...

Asian stocks rose to their highest in six weeks on Friday and a blistering rally in precious metals showed no signs of ...

Bank of America's Vivek Arya sees a 30% surge in chip sales and a $900 billion accelerator market just over the horizon.

Not every pullback is a buying opportunity. Some downticks are earned. However, sometimes a stock falls out of favor when the business is holding up better than the chart may suggest. If you have a ...

This is the fourth in a series of articles in which I'm ranking the best "Magnificent Seven" stocks to buy for 2026, in ...

Japan’s stocks are expected to extend gains in 2026, with Prime Minister Sanae Takaichi’s aggressive fiscal plans building on ...

The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...

REITs are out of favor, offering dividend investors a chance to buy industry leaders while they have attractive yields.

The iShares MSCI Spain ETF remains a strong buy for 2026, with robust GDP growth, sector strength, and a 2.28% dividend yield ...